Renaissance Technologies - INVIVO THERAPEUTICS HLDGS CO ownership

Back to all holdings Add to watchlist

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 58 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Renaissance Technologies ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q2 2018$86,0000.0%159,9000.0%0.00%–
Q1 2018$86,000
-61.1%
159,900
+404.4%
0.00%–
Q1 2016$221,000–31,700–0.00%–
 Download
Other shareholders

There were no reported owners of INVIVO THERAPEUTICS HLDGS CO in Q1 2016.

NameSharesValueWeighting ↓
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders